Zenas

ArgenX

This company develops and commercialises antibody-based therapies to treat patients suffering from severe autoimmune diseases and cancer.

X4 Pharmaceuticals

This biopharmaceutical company develops and commercialises oral therapies for patients with rare immune system disorders, such as WHIM syndrome and chronic neutropenia.

Kezar Life Sciences

This clinical-stage biopharmaceutical company develops small-molecule therapeutics for patients with autoimmune diseases and inflammatory conditions.

Selecta Biosciences

This biopharmaceutical company develops nanoparticle immunomodulatory drugs to treat and prevent human diseases for patients with autoimmune disorders and rare genetic conditions.

Ouro Medicines

This biotechnology firm develops T-cell engager therapies to treat patients living with chronic immune-mediated diseases.

LTZ Therapeutics

This biopharma company develops myeloid engager immunotherapies for patients with cancer and autoimmune diseases.

Landos Biopharma

This company develops oral medicines for patients with autoimmune diseases, specifically targeting inflammatory bowel diseases such as ulcerative colitis and Crohn's disease.

APLS

This biopharmaceutical company develops complement-based therapies to treat autoimmune and inflammatory diseases for patients with conditions like paroxysmal nocturnal haemoglobinuria and geographic atrophy.